A225220 logo

Genolution Inc. Stock Price

KOSDAQ:A225220 Community·₩33.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A225220 Share Price Performance

₩0
-2970.00 (-100.00%)
₩0
-2970.00 (-100.00%)
Price ₩0

A225220 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Excellent balance sheet with minimal risk.

1 Risk
1 Reward

Genolution Inc. Key Details

₩9.1b

Revenue

₩5.1b

Cost of Revenue

₩4.0b

Gross Profit

₩12.1b

Other Expenses

-₩8.1b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-446.07
44.03%
-88.12%
32.6%
View Full Analysis

About A225220

Founded
2006
Employees
n/a
CEO
Ki-Ok Kim
WebsiteView website
genolution.co.kr

Genolution Inc. manufactures and sells IVD medical instruments in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and double-stranded RNA (dsRNA) synthesis technology. The company offers Nextractor NX-Duo, Nextractor NX-32N/45N, Nextractor NX-Jr, Nextractor NX-24SA, NGS library preparation equipment, DNA/RNA extraction kits. It also develops and manufactures instruments and reagents for DNA/RNA; provides long dsRNA synthesis services; and siRNA/miRNA/shRNA synthesis service and related products. Genolution Inc. was founded in 2006 and is based in Seoul, South Korea.

Recent A225220 News & Updates

Is Genolution (KOSDAQ:225220) Using Debt In A Risky Way?

May 22
Is Genolution (KOSDAQ:225220) Using Debt In A Risky Way?

Recent updates

No updates